|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's range||97.13 - 97.13|
|52-week range||88.75 - 112.65|
|Beta (5Y monthly)||0.40|
|PE ratio (TTM)||17.95|
|Forward dividend & yield||3.86 (3.97%)|
|Ex-dividend date||05 May 2021|
|1y target est||N/A|
Dr. Arthur Caplan, NYU Langone Health, Division of Medical Ethics at NYU School of Medicine, joins Yahoo Finance to discuss the latest on the coronavirus vaccines and booster shots.
Availability of the Q3 2021 Memorandum for modelling purposes Paris, France – September 24, 2021 - Sanofi announced today that its Q3 2021 Memorandum for modelling purposes is available on the "Investors" page of the company's website: https://www.sanofi.com/en/investors/financial-results-and-events/financial-results/Q3-results-2021 As for each quarter, Sanofi prepared this document to assist in the financial modelling of the Group's quarterly results. This document includes a reminder on variou
Dr. Cedric Dark, Assistant Professor at Baylor College of Medicine & Board Member with Doctors for America, joins Yahoo Finance to discuss the latest on the coronavirus pandemic.